Page last updated: 2024-08-23

daunorubicin and Kaposi Sarcoma

daunorubicin has been researched along with Kaposi Sarcoma in 41 studies

Research

Studies (41)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	30 (73.17)	18.2507
2000's	10 (24.39)	29.6817
2010's	1 (2.44)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bendle, M; Bower, M; Papanastasopoulos, P; Pealing, J	1
Boronovskaia, LE; Korman, DB; Maslova, IA; Mikaélian, SG	1
Krown, SE; Northfelt, DW; Osoba, D; Stewart, JS	1
Bennett, CL; Calhoun, EA	1
Andreone, P; Bernardi, M; Calza, L; Chiodo, F; Giuliani, R; Manfredi, R; Tadolini, M; Trevisani, F; Verucchi, G; Zambruni, A	1
Chew, T; Jacobs, M	1
Dittmer, DP; Petre, CE	1
Cabriales, S; Espina, BM; Esplin, JA; Forssen, E; Gill, PS; Levine, AM; Liebman, HA; Muggia, F; Ross, ME; Tulpule, A	1
Dormann, A; Grünewald, T; Ruf, B; Schürmann, D	1
Blayney, DW; Flanagan, B; Kennedy, P; Lisak, J; Presant, CA; Presant, J; Scolaro, M	1
Bates, F; Boag, FC; Gazzard, BG; Money-Kyrle, JF; Phillips, RH; Ready, J	1
Cohen, P; Gill, PS; Gonzales, G; Jacobs, M; Kempin, S; Mukwaya, GM; Myers, AM; Pike, MC; Rarick, MU; Ross, ME; Sawka, C; Scadden, DT; Shepherd, F; Silverberg, I; von Roenn, JH; Wernz, J	1
Boag, F; Bower, M; Gazzard, BG; Hannon, F; Money-Kyrle, J; Muyshondt, C; Phillips, R; Uthayakumar, S; Youle, M	1
Bouchaud, O; Eestermans, G; Girard, PM; Goetschel, A; Mukwaya, G; Ross, M; Rozenbaum, W; Saimot, AG	1
Dupont, B; Eliaszewicz, M; Feuillie, V; Fournier, S; Gonzalez-Canali, G; Pialoux, G	1
White, RM	1
Aboulafia, DM; Bennett, CL; Bogner, J; Goebel, FD; Golub, RM; Stewart, S; Stinson, TJ; von Roenn, J	1
Boswell, W; Cabriales, S; Espina, BM; Gill, PS; Ilaw, M; Myers, A; Scadden, DT; Tulpule, A; Wernz, J; Yung, RC	1
Badiaga, S; Brouqui, P; Parola, P; Zandotti, C	1
Canal, P; Chatelut, E; Couderc, F; Nertz, M; Siméon, N	1
Goebel, FD; Jablonowski, H	1
Bennett, C; Hjortsberg, C; Lidbrink, E; Persson, U	1
Careddu, A; D'Incalci, M; Fumagalli, L; Lazzarin, A; Parisi, I; Viganò, MG; Zecca, B; Zucchetti, M	1
Pozo, F; Rivero, A; Serrano, R; Tenorio, A; Torre-Cisneros, J; Vidal, E	1
Muggia, FM	1
Blay, JY; Boulez, J; Fléchon, A; Lombard-Bohas, C; Scoazec, JY	1
Wernz, JC	1
Link, D	1
Cacoub, P; Poizot-Martin, I; Rosenthal, E; Saint-Marc, T; Spano, JP	1

Reviews

5 review(s) available for daunorubicin and Kaposi Sarcoma

Article	Year
Use of liposomal anthracyclines in Kaposi's sarcoma. Seminars in oncology, 2004, Volume: 31, Issue:6 Suppl 13 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Humans; Liposomes; Quality of Life; Sarcoma, Kaposi	2004
Pharmacoeconomics of liposomal anthracycline therapy. Seminars in oncology, 2004, Volume: 31, Issue:6 Suppl 13 Topics: Anthracyclines; Antibiotics, Antineoplastic; Costs and Cost Analysis; Daunorubicin; Doxorubicin; Female; Humans; Liposomes; Male; Multiple Myeloma; Ovarian Neoplasms; Sarcoma, Kaposi	2004
Pharmacology of liposomal daunorubicin and its use in Kaposi's sarcoma. Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:6 Suppl Topics: Antibiotics, Antineoplastic; Daunorubicin; Drug Carriers; Humans; Liposomes; Sarcoma, Kaposi	1996
Liposomal daunorubicin as treatment for Kaposi's sarcoma. International journal of nanomedicine, 2007, Volume: 2, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Chemistry, Pharmaceutical; Daunorubicin; Drug Carriers; Humans; Liposomes; Nanomedicine; Sarcoma, Kaposi; Treatment Outcome	2007
Liposomal encapsulated anthracyclines: new therapeutic horizons. Current oncology reports, 2001, Volume: 3, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Liposomes; Lymphoma; Multiple Myeloma; Ovarian Neoplasms; Sarcoma, Kaposi	2001

Trials

14 trial(s) available for daunorubicin and Kaposi Sarcoma

Article	Year
[Results of a phase I-II clinical trial of Emoxyl, a novel antineoplastic anthracycline]. Voprosy onkologii, 2004, Volume: 50, Issue:2 Topics: Aged; Anthracyclines; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Small Cell; Daunorubicin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Sarcoma, Kaposi; Treatment Outcome	2004
Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Cohort Studies; Daunorubicin; Drug Carriers; Female; Half-Life; Humans; Liposomes; Male; Middle Aged; Neutropenia; Prognosis; Remission Induction; Sarcoma, Kaposi; Survival Rate	1995
Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. Lancet (London, England), 1993, May-15, Volume: 341, Issue:8855 Topics: Acquired Immunodeficiency Syndrome; Adult; Daunorubicin; Drug Carriers; Humans; Liposomes; Lung Neoplasms; Pharyngeal Neoplasms; Quality of Life; Remission Induction; Sarcoma, Kaposi; Treatment Outcome	1993
Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study. Clinical oncology (Royal College of Radiologists (Great Britain)), 1993, Volume: 5, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Daunorubicin; Drug Carriers; Humans; Liposomes; Male; Middle Aged; Neutropenia; Recurrence; Sarcoma, Kaposi; Treatment Outcome	1993
Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adult; Alopecia; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Daunorubicin; Doxorubicin; Drug Carriers; Female; Humans; Liposomes; Male; Middle Aged; Neutropenia; Prospective Studies; Remission Induction; Sarcoma, Kaposi; Survival Rate; Treatment Failure; United States; Vincristine	1996
Randomized cross-over comparison of liposomal daunorubicin versus observation for early Kaposi's sarcoma. AIDS (London, England), 1996, Volume: 10, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Cross-Over Studies; Daunorubicin; Drug Carriers; Humans; Liposomes; Male; Sarcoma, Kaposi	1996
Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma. AIDS (London, England), 1996, Volume: 10, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Antibiotics, Antineoplastic; Daunorubicin; Disease Progression; Drug Carriers; Humans; Liposomes; Male; Middle Aged; Reaction Time; Remission Induction; Sarcoma, Kaposi	1996
Efficacy and tolerance of liposomal daunorubicin in Kaposi sarcoma associated with human immunodeficiency virus infection. Archives of dermatology, 1997, Volume: 133, Issue:7 Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; CD4 Lymphocyte Count; Daunorubicin; Digestive System Neoplasms; Disease Progression; Drug Carriers; Humans; Liposomes; Lung Neoplasms; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate	1997
Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcoma. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Aug-15, Volume: 18, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Cost-Benefit Analysis; Daunorubicin; Decision Support Techniques; Doxorubicin; Drug Carriers; Humans; Liposomes; Sarcoma, Kaposi; Sensitivity and Specificity	1998
Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Adult; Antibiotics, Antineoplastic; Daunorubicin; Drug Administration Schedule; Humans; Liposomes; Lung; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Sarcoma, Kaposi; Survival Analysis	1998
Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal. European journal of medical research, 1999, Dec-16, Volume: 4, Issue:12 Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antiviral Agents; Cost-Benefit Analysis; Daunorubicin; Doxorubicin; Hepatitis C, Chronic; Herpesvirus 8, Human; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Sarcoma, Kaposi	1999
The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma. Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:6 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antibiotics, Antineoplastic; Daunorubicin; Drug Interactions; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Indinavir; Liposomes; Male; Middle Aged; Ritonavir; Saquinavir; Sarcoma, Kaposi	2000
Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin. AIDS (London, England), 2000, Sep-29, Volume: 14, Issue:14 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Daunorubicin; Didanosine; Drug Therapy, Combination; Herpesvirus 8, Human; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Stavudine; Viremia	2000
Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma. American journal of clinical oncology, 2002, Volume: 25, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Antibiotics, Antineoplastic; Antiretroviral Therapy, Highly Active; Daunorubicin; Female; Humans; Liposomes; Male; Middle Aged; Sarcoma, Kaposi	2002

Other Studies

22 other study(ies) available for daunorubicin and Kaposi Sarcoma

Article	Year
Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi's sarcoma (KS). Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:3 Topics: Adolescent; Adult; Aged; Anthracyclines; Anti-HIV Agents; Antibiotics, Antineoplastic; Daunorubicin; Follow-Up Studies; HIV Infections; Humans; Liposomes; Male; Middle Aged; Neoplasms, Second Primary; Risk Factors; Sarcoma, Kaposi; Treatment Outcome; Viral Load; Young Adult	2014
Human herpesvirus-8-related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin. Transplant infectious disease : an official journal of the Transplantation Society, 2005, Volume: 7, Issue:1 Topics: Antibiotics, Antineoplastic; Antiviral Agents; Cidofovir; Cytosine; Daunorubicin; Drug Therapy, Combination; Herpesvirus 8, Human; Humans; Immunocompromised Host; Liver Transplantation; Male; Middle Aged; Organophosphonates; Sarcoma, Kaposi; Viral Load; Viremia	2005
Successful treatment of AIDS-related pulmonary Kaposi's sarcoma with liposomal daunorubicin. The European respiratory journal, 1994, Volume: 7, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Daunorubicin; Humans; Liposomes; Lung Neoplasms; Male; Radiography; Sarcoma, Kaposi	1994
Liposomal daunorubicin marketed for HIV-related Kaposi's sarcoma. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996, Jul-01, Volume: 53, Issue:13 Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Daunorubicin; Drug Approval; Drug Carriers; Humans; Liposomes; Sarcoma, Kaposi; United States; United States Food and Drug Administration	1996
DaunoXome data presented at international cancer meeting. Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Daunorubicin; Doxorubicin; Drug Carriers; HIV Infections; Humans; Liposomes; Lung Neoplasms; Sarcoma, Kaposi; Vinblastine	1996
[New data: daunoxome against Kaposi sarcoma. Fifth European Conference on clinical aspects and treatment of HIV infection]. Pharmazie in unserer Zeit, 1996, Volume: 25, Issue:1 Topics: Antibiotics, Antineoplastic; Daunorubicin; HIV Infections; Humans; Sarcoma, Kaposi	1996
Mislabeling of drug for Kaposi's sarcoma rectified. The Journal of the American Osteopathic Association, 1997, Volume: 97, Issue:8 Topics: Clinical Trials, Phase III as Topic; Daunorubicin; Dose-Response Relationship, Drug; Drug Labeling; HIV Infections; Humans; Liposomes; Sarcoma, Kaposi; United States; United States Food and Drug Administration	1997
Liposomal daunorubicin is not recommended in patients with less than advanced HIV-related Kaposi's sarcoma. AIDS (London, England), 1997, Volume: 11, Issue:11 Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Clinical Trials as Topic; Cross-Over Studies; Daunorubicin; Drug Carriers; HIV Infections; Humans; Immunocompromised Host; Liposomes; Sarcoma, Kaposi	1997
Successful treatment of Kaposi's sarcoma with a combination of antiviral drug therapy and chemotherapy: two case reports. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 27, Issue:6 Topics: Adult; Antibiotics, Antineoplastic; Antiviral Agents; Cidofovir; Cytosine; Daunorubicin; Drug Therapy, Combination; Humans; Male; Organophosphonates; Organophosphorus Compounds; Sarcoma, Kaposi; Treatment Outcome	1998
Liposomal daunorubicin: new preparation. Kaposi's sarcoma: occasional remission. Prescrire international, 1998, Volume: 7, Issue:34 Topics: Antibiotics, Antineoplastic; Clinical Trials as Topic; Daunorubicin; Drug Carriers; Drug Evaluation; France; Humans; Liposomes; Neutropenia; Remission Induction; Sarcoma, Kaposi; Time Factors; Treatment Outcome	1998
Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma. Prescrire international, 1998, Volume: 7, Issue:35 Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Carriers; Drug Evaluation; Humans; Liposomes; Sarcoma, Kaposi; Treatment Outcome; Vincristine	1998
Anthracycline analysis by capillary electrophoresis. Application to the analysis of daunorubicine in Kaposi sarcoma tumor. Journal of chromatography. A, 1999, Aug-20, Volume: 853, Issue:1-2 Topics: Antibiotics, Antineoplastic; Biopsy; Chromatography, High Pressure Liquid; Daunorubicin; Electrophoresis, Capillary; Fluorescence; Humans; Lasers; Sarcoma, Kaposi	1999
Cost-effectiveness analysis of pegylated-liposomal doxorubicin and liposomal daunorubicin treatments in patients with Kaposi's sarcoma. Acta oncologica (Stockholm, Sweden), 1999, Volume: 38, Issue:8 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cost-Benefit Analysis; Daunorubicin; Doxorubicin; Drug Carriers; Drug Costs; HIV Infections; Humans; Liposomes; Polyethylene Glycols; Randomized Controlled Trials as Topic; Retrospective Studies; Sarcoma, Kaposi; Sweden	1999
Complete response of an HIV negative gastric Kaposi's sarcoma (KS) patient with peritoneal carcinomatosis by liposomal daunorubicin treatment. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:2 Topics: Adult; Antibiotics, Antineoplastic; Carcinoma; Daunorubicin; HIV Seronegativity; Humans; Liposomes; Male; Peritoneal Neoplasms; Sarcoma, Kaposi; Stomach Neoplasms	2001
Liposomal drug targeting in the treatment of Kaposi's sarcoma. AIDS patient care and STDs, 1996, Volume: 10, Issue:6 Topics: Adult; Antibiotics, Antineoplastic; Daunorubicin; Drug Carriers; HIV Infections; Humans; Liposomes; Male; Middle Aged; Sarcoma, Kaposi; Treatment Outcome	1996
DaunoXome approved. AIDS patient care and STDs, 1996, Volume: 10, Issue:4 Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Carriers; HIV Infections; Humans; Liposomes; Sarcoma, Kaposi	1996
Kaposi's sarcoma: DaunoXome approved. AIDS treatment news, 1996, May-03, Issue:no 246 Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Approval; Drug Carriers; HIV Infections; Humans; Liposomes; Sarcoma, Kaposi; United States; United States Food and Drug Administration	1996
FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration. Journal of the International Association of Physicians in AIDS Care, 1996, Volume: 2, Issue:5 Topics: Antineoplastic Agents; Daunorubicin; Drug Approval; Drug Carriers; HIV Infections; Humans; Liposomes; Quality of Life; Sarcoma, Kaposi; Treatment Outcome; United States; United States Food and Drug Administration	1996
DaunoXome offers KS treatment alternative. AIDS alert, 1996, Volume: 11, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Approval; Humans; Sarcoma, Kaposi; United States; United States Food and Drug Administration	1996
Liposomal KS drugs approved. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1996, Volume: 10, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Agents; Daunorubicin; Doxorubicin; Drug Carriers; Drug Costs; Humans; Liposomes; Sarcoma, Kaposi	1996
New York ADAP to cover new AIDS drugs plus viral load testing. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1996, Volume: 10, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Antiviral Agents; Cytomegalovirus Infections; Daunorubicin; Drug Costs; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Insurance, Pharmaceutical Services; Lobbying; Nevirapine; New York; Pyridines; Sarcoma, Kaposi	1996
Paclitaxel for treating KS. Project Inform perspective, 1997, Issue:23 Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Carriers; Humans; Liposomes; Paclitaxel; Sarcoma, Kaposi	1997